Bioxcel Therapeutics Logo

Innovative Medicine Backed by the Power of AI

BioXcel Therapeutics, Inc. is a
commercial-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, approaches.

Innovative Medicine
Backed by the
Power of AI

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.

Innovative Medicine
Backed by the Power of AI

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.

Our Approach to Drug Development

AI-based Drug Development

Our neuroscience and immuno-oncology franchises utilize our AI
approach to drug identification and development

Neuroscience

BXCL501-Neuroscience-image

Immuno-Oncology

BXCL701-Immuno-Oncology-image

Latest News

Jun 17, 2022
Addressing Alzheimer Agitation With Phase 3 TRANQUILITY Program of BXCL501VIEW RELEASE
Jun 07, 2022
BioXcel Therapeutics to Participate at Two Upcoming Investor ConferencesVIEW RELEASE
Jun 06, 2022
Vimal Mehta Recognized for Leadership in New Haven Biz Power 25: Healthcare 2022 ListVIEW RELEASE

Stock Information

BioXcel Therapeutics, Inc.

Jun 24, 2022 04:00 PM

MARKET/SYMBOL

Nasdaq:

BTAI

PRICE

12.11

CHANGE

0.05 (0.41%)